-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Researchers recently looked at the risk of primary sclerotic bileitis (PSC) in patients with inflammatory bowel disease (IBD).
between April 2006 and April 2016, researchers followed IBD patients to collect PSC(PSC-IBD) data, which, as of April 2019, covered hospital visits, imaging and endoscopic assessments, surgery, cancer and death.
the main purpose of this study was to quantify the risk of developing PSC in all IBD subtype patients and to assess its impact on liver and bile disease, IBD-related outcomes and all-cause mortality based on sex, race and age.
10 years, researchers have collected information on 284,560 IBD patients nationwide, 2,588 of which have PSC.
total of 31,587 colonectomies, 5608 colorectal cancer (CRC) removals, 6608 gallbladder excisions and 41,055 patient deaths were performed.
IBD patients developed PSC associated with an increased risk of death and CRC (risk ratio of 3.20 and 2.43, respectively), and the middle age of CRC diagnosis in IBD-PSC patients was lower (59 years vs 69 years).
compared to patients with pure IBD, if diagnosed with PSC-IBD under 40 years of age, the above-mentioned PSC-IBD patients had a four-fold increased risk of CRC, and PSC-IBD also increased bile tube cancer (HR: 28.46), risk of hepatocellular carcinoma (HR:21.00), pancreatic cancer (HR:5.26) and gallbladder cancer (HR:9.19).
patients who were examined for PSC-IBD had a lower risk of death associated with liver and pancreatic bile tube cancer (HR, 0.43) than those who did not receive an imaging test.
the largest difference in mortality between the PSC-IBD group and the IBD group alone were among patients under 40 years of age (risk ratio >7), while those over 60 years of age had a smaller difference (risk ratio of 1.5).
in PSC-IBD patients, the researchers observed 173 first liver transplants.
of patients under the age of 40 diagnosed with PSC, liver transplantation and PSC-related events accounted for about 75 per cent of clinical events, compared with 31 per cent over the age of 60.
increased risk of transplantation or PSC-related death in African and Caribbean populations (HR:2.05) compared to white populations, while the risk of transplantation or death was lower in female patients (HR:0.74).
study found an increased risk of colon cancer, liver and pancreatic bile tube cancer and death in patients with inflammatory bowel disease associated with primary sclerotic bileitis.
poor prognosm for people aged 40 and under, men and people of African-Caribbean descent.
.